Related Experiment Video

Updated: Aug 6, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis

G Davies1, A U Wells, S Doffman

  • 1Host Defence Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK.

The European Respiratory Journal
|August 11, 2006
PubMed

Insights

Pseudomonas aeruginosa infection in bronchiectasis is linked to worse lung function but does not accelerate disease decline. This bacterium serves as an indicator of disease severity, not a cause of progression.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Bronchiectasis patients frequently develop Pseudomonas aeruginosa infections.
  • Pseudomonas aeruginosa infection is associated with increased disease severity, airflow obstruction, and reduced quality of life.
  • The role of Pseudomonas aeruginosa in bronchiectasis progression remains unclear.

Purpose of the Study:

  • To investigate whether Pseudomonas aeruginosa infection indicates bronchiectasis severity or contributes to disease progression.
  • To analyze the relationship between Pseudomonas aeruginosa status and pulmonary function decline over time.

Main Methods:

  • A cohort of 163 non-cystic fibrosis adult bronchiectasis outpatients were categorized into "never infected," "intermittently isolated," and "chronically infected" groups based on sputum cultures for Pseudomonas aeruginosa.
  • Pulmonary function tests, including forced expiratory volume in one second (FEV(1)) and diffusing capacity of the lung for carbon monoxide (DLCO), were assessed at baseline and over a minimum of two years.
  • Longitudinal changes in FEV(1) were classified as improvement, decline, or stability.

Main Results:

  • Patients with Pseudomonas aeruginosa infection, particularly chronic infection, had significantly lower baseline FEV(1), FEV(1)/forced vital capacity ratios, and DLCO compared to never-infected patients.
  • While baseline lung function influenced longitudinal changes (lower function associated with improvement or decline), the rate of pulmonary function decline did not differ significantly between the infection groups, even after adjusting for baseline FEV(1).

Conclusions:

  • Pseudomonas aeruginosa infection in bronchiectasis is a marker of more severe pulmonary impairment at baseline.
  • Pseudomonas aeruginosa infection does not appear to accelerate the rate of pulmonary function decline in bronchiectasis patients.
  • The findings suggest Pseudomonas aeruginosa is an indicator of bronchiectasis severity rather than a driver of accelerated disease progression.

More Related Videos

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...